Clinical Trial Update: Rivaroxaban in Left Ventricular Thrombus [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating rivaroxaban for left ventricular thrombus in acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Left Ventricular Thrombus

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: National Institute of Cardiovascular Diseases, Pakistan | Conditions: Acute Coronary Syndrome, Left Ventricular Thrombus | Phase 4 | Status: COMPLETED